URL has been copied successfully!
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
AbbVie (NYSE:ABBV)
- Dividend Yield: 3.39%
- Piper Sandler analyst David Amsellem maintained an Overweight rating and cut the price target from $299 to $294 on April 23, 2026. This analyst has an accuracy rate of 76%
- Canaccord Genuity analyst Gary Nachman initiated coverage on the stock with a Buy rating and a price target of $262 on April 21, 2026. This analyst has an accuracy rate of 59%.
- Recent News: On April 29, AbbVie posted better-than-expected first-quarter earnings.
- Benzinga Pro’s real-time …
Please follow us:
This post was originally published here
